South Dakota Investment Council’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

South Dakota Investment Council’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-473,714	Closed	-$327K	–	659
2020 Q4	$327K	Sell	473,714 -34,000	-7%	-$72.4K	0.01%	552
2020 Q3	$1.14M	Buy	507,714 +20,300	+4%	+$58K	0.03%	393
2020 Q2	$1.75M	Buy	487,414 +66,360	+16%	+$239K	0.04%	315
2020 Q1	$1.6M	Hold	421,054	–	–	0.04%	297
2019 Q4	$1.27M	Buy	+421,054	New	+$1.09M	0.03%	389

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

South Dakota Investment Council's BMY.RT Position: Q1 2021 in Review

South Dakota Investment Council sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 473,714 shares — an estimated $327K sold.

South Dakota Investment Council first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.75M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

South Dakota Investment Council reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
South Dakota Investment Council sold 473,714 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $327K.
South Dakota Investment Council first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
South Dakota Investment Council's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.75M in Q2 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on South Dakota Investment Council's 13F filing for Q1 2021, filed 13 May 2021.